Quantcast
Last updated on April 24, 2014 at 14:55 EDT

Latest Cardiac electrophysiology Stories

2014-04-23 16:29:55

Pacemaker placed in patient's heart without any chest incision SAN DIEGO, April 23, 2014 /PRNewswire/ -- Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim(TM) leadless pacemaker, the world's first wireless pacemaker totally implanted in the heart, as part of the Leadless II Clinical Trial. Developed for patients with bradycardia - a heart rate that is too slow - the Nanostim(TM) is placed directly in a patient's heart...

2014-04-22 08:35:03

NATICK, Mass., April 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has conducted the first implant in the clinical trial of the next generation ACUITY(TM) X4 left-ventricular (LV) pacing leads and RELIANCE(TM) 4-FRONT defibrillation (ICD) leads. The clinical trial is designed to establish the safety and effectiveness of both lead families and is intended to support U.S. Food and Drug Administration (FDA) approval of these devices. ACUITY X4 LV leads are...

2014-04-18 16:22:54

- Led by New Enterprise Associates and Experienced Medical Device Industry Veterans, Financing Will Support Development of Next Generation TempaSure(TM) Radiometric Temperature-Sensing Radio-Frequency Ablation Catheter Capable of Accurate, Real-Time Volumetric Temperature Measurement During Irrigated Ablation MENLO PARK, Calif., April 18, 2014 /PRNewswire/ -- Advanced Cardiac Therapeutics, Inc. ("ACT"), a medical device company that is developing a novel, temperature-sensing,...

2014-04-17 23:07:19

ChanTest, in collaboration with Dr. Philip Sager, are seeking multi-stakeholder input to move towards using non-clinical in vitro human models to assess a drug’s cardiac safety Cleveland, OH (PRWEB) April 17, 2014 ChanTest, the world’s most trusted ion channel expert, announces a complementary webinar entitled “Making Sense of the CiPA Initiative: a Paradigm Shift in Cardiac Safety”. The webinar will be moderated by Cambridge Healthtech Associates™ (CHA) and is scheduled to take...

2014-04-15 16:28:34

NATICK, Mass., April 15, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN(TM) MINI and INOGEN(TM) MINI ICDs, as well as the DYNAGEN(TM) X4 and INOGEN(TM) X4 CRT-Ds. The X4 line of quadripolar CRT-Ds offers 70 percent more pacing options to address high capture thresholds and phrenic nerve...

2014-04-14 23:02:11

Improved operational efficiency, falling semiconductor and electronic component costs, and rising competition within the wholesale market have lowered production costs and driven prices downward in recent years. For these reasons and to help procurement professionals make better buying decisions faster, business intelligence firm IBISWorld has added a report on the procurement of Automated External Defibrillators to its growing collection of procurement category market research reports....

2014-04-10 23:22:55

Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development Philadelphia (PRWEB) April 10, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has entered into an agreement with GE Healthcare that enables ERT to introduce the QT Guard Plus Analysis System to the clinical trial industry as part of its centralized cardiac safety solutions. The QT Guard Plus Analysis...

2014-04-07 16:24:06

Protecting players, coaches and parents from sudden cardiac arrest top priority ROCKVILLE CENTRE, N.Y., April 7, 2014 /PRNewswire/ -- It's almost two years to the day when soccer fans across the world watched in horror as star midfielder Fabrice Muamba suffered sudden cardiac arrest (SCA) during a tournament match. He was revived with an automated external defibrillator (AED) but his story illustrates how SCA, which accounts for 360,000 deaths annually in the United States, can...

2014-04-07 16:23:52

LONDON, April 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:MediPoint: Cardiac Rhythm Management - Current and Future PlayersMediPoint: Cardiac Rhythm Management - Current and Future PlayersSummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve...

2014-04-03 12:25:56

Pilot trial shows blood test much more effective than current risk stratifications A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD). That paper by Samuel C. Dudley, M.D., Ph.D, chief of cardiology at the CVI, is published online in...


Latest Cardiac electrophysiology Reference Libraries

Electrocardiography
2013-04-30 09:55:53

Electrocardiography, sometimes called ECG or EKG, is a measurement of the electrical activity of the heart as the linear process unfolds. With the use of electrodes that are attached to the skin, this non-invasive test can provide vast information as to the patient’s status. By leaving the electrodes attached, the patient’s status can be monitored over intervals of time and recorded on the device. This data can be sent electronically for consults about potential treatments without delay....

More Articles (1 articles) »